Natco Drug Discovery Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.10 M
as on 15-11-2024
- Company Age 35 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Ebitda
- Net Worth -0.01%
(FY 2023)
- Total Assets -30.17%
(FY 2023)
About Natco Drug Discovery
The Corporate was formerly known as Natchem Pharma Pvt Ltd.. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pathuri Rao and Sadasiva Nannapaneni serve as directors at the Company.
- CIN/LLPIN
U24230TG1989PTC009942
- Company No.
009942
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 1989
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Natco Drug Discovery?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pathuri Rao  | Director | 19-Jun-2002 | Current |
| Sadasiva Nannapaneni | Director | 01-Jul-2016 | Current |
Financial Performance of Natco Drug Discovery.
Natco Drug Discovery Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Natco Drug Discovery?
In 2023, Natco Drug Discovery had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Time Cap Pharma Labs Private LimitedActive 36 years 10 monthsSadasiva Nannapaneni is a mutual person
- Natsoft Information Systems Private LimitedActive 26 years 5 months
Sadasiva Nannapaneni is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Natco Drug Discovery?
Unlock and access historical data on people associated with Natco Drug Discovery, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Natco Drug Discovery, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Drug Discovery's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
